With fully automated next-generation sequencing and software, we deliver clarity in infectious disease and oncology research.
For Research Use Only. Not for use in diagnostic procedures.
Clinical Diagnostic Solutions
Our comprehensive whole genome sequencing (WGS) platform accelerates detection of infectious disease outbreaks and helps inform the action required to manage public outbreaks.
Food Safety Diagnostic Solutions
We leverage next-generation sequencing (NGS) to completely reinvent the way that food is tested and analyzed before it’s consumed by millions of people each day.
Delivering Clarity
From food safety testing to clinical diagnostics, our team of genomics scientists and software engineers are committed to developing innovative solutions that contribute to pathogen and infectious disease surveillance.
Association for Molecular Pathology
Clear Labs will be showcasing our latest venture into the Oncology space during the Innovation Spotlight Stage (ISS #3) on 11/13/2025 at AMP 2025, featuring Ramin Khaksar, CSO & COO of Clear Labs, Dr Thomas Stricker from OneOncology and Shi...
PRWeb
Clear Labs announced the launch of its newest innovation: an enhanced Clear Dx™ System with additional capabilities and the Clear Dx™ Microbial ID tNGS assay workflow. This end-to-end automated solution enables next-day identification o...
Great Entrepreneurs
We’re proud to announce that our Co-founder and CEO, Sasan Amini, has been recognized as one of the Top 50 Healthcare AI Entrepreneurs of 2025 by Great Entrepreneurs! This honor highlights the groundbreaking work we’re doing at Clear L...
PRWeb
This round of financing was led by a strategic investor, along with participation from existing investors, including Counterpoint Global (Morgan Stanley), Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile...
Journal of Food Protection
In this study, an automated, targeted next-generation sequencing (tNGS) assay to detect and serotype Salmonella from sample enrichments was evaluated. The assay generates millions of reads to detect multiple Salmonella-specific genes and se...
Clear Labs
Clear Labs announces the launch of Clear Dx™ FlexPro: Wastewater (SARS-CoV-2), a fully automated end-to-end whole genome sequencing (WGS) solution for sequencing SARS-CoV-2 in wastewater.
PRWeb
Clear Labs announces the launch of the Clear Dx™ Microbial Surveillance WGS, a fully-automated, end-to-end whole genome sequencing (WGS) solution for bacterial and fungal isolates.
Health Tech World
Who is having a real impact on healthcare and digital health? Which innovations will positively affect healthcare in 2023? Here’s the Health Tech World longlist of some of the most prominent names in the space, and Clear Labs is among the...
Genome Web
During the pandemic, Clear Labs expanded the market for its automated sequencing system from environmental pathogen detection in the food industry to SARS-CoV-2 surveillance and wastewater monitoring. Now, the San Carlos, California-based c...
BioProcess International
As an entrepreneur, I stepped away from a fulfilling position in a large and established company to go out on my own and build something new. My decision to leave the advanced research department at Illumina, Inc. to create a start-up might...
The needs for infectious disease and oncology research are evolving-and so is our technology. By combining fully automated sequencing with intuitive software and bioinformatics pipelines, we've created a comprehensive, turnkey next-generation sequencing platform that accelerates and advances our understanding of pathogens and cancer. For Research Use Only. Not for use in diagnostic procedures.
From identifying specific pathogen sources and strains, to helping companies gain greater operational awareness, our unique tests leverage a next-generation sequencing (NGS) food safety testing platform to ensure consumer safety.
